Elliot Norry insider trades
Open-market stock purchases and sales by Elliot Norry, Chief Medical Officer at Adaptimmune Therapeutics plc, from SEC Form 4 filings since Jan 14, 2020.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- ADAP Adaptimmune Therapeutics plc: 21 sales, last Feb 20, 2025